S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

NUVB Panacea Acquisition Corp

2.77

-0.05 (-1.77%)

Last Updated: 10:32:09

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Panacea Acquisition (NYSE:NUVB)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Panacea Acquisition Charts.

Panacea Acquisition (NYSE:NUVB)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Panacea Acquisition Charts.

Panacea Acquisition Corp News

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer
Monday 23 December 2024 (3 days ago) • Business Wire

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Friday 20 December 2024 (6 days ago) • PR Newswire (US)

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
Tuesday 26 November 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Nuvation Bio to Present at the Jefferies London Healthcare Conference
Tuesday 12 November 2024 (1 month ago) • Business Wire

Form 8-K - Current report
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
Wednesday 6 November 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 10 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 9 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 9 October 2024 (3 months ago) • Edgar (US Regulatory)

Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer
Monday 7 October 2024 (3 months ago) • Business Wire

More Panacea Acquisition Corp News Articles

Elite Pharmaceuticals (QB)

North Bay Resources (PK)

Voip Pal Com (QB)

Northwest Biotherapeutics (QB)

Good Vibrations Shoes (PK)

KULR Technology

Anavex Life Sciences

Code Green Apparel (PK)

Fannie Mae (QB)

Lightwave Logic

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions